跳至主要内容
临床试验/NCT07746531
NCT07746531尚未招募不适用

ROBOTIC MINIMALLY INVASIVE HYSTERECTOMY POST-MARKET CLINICAL STUDY WITH THE DEXTER ROBOTIC SURGERY SYSTEM

Distalmotion SA2 个研究点 分布在 1 个国家目标入组 112 人开始时间: 2026年8月7日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
112
试验地点
2
主要终点
Primary safety outcome

研究概览

简要总结

The purpose of this post-market, observational study is to collect real-world data under anticipated conditions of use that demonstrates that the device performs as intended (accurate, precise control of surgical instruments) in patients undergoing robotic-assisted and laparoscopic hysterectomy for benign disease.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
22 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Patient is ≥ 22 years of age at time of enrollment/consent
  • Patient is planned to undergo robotic-assisted and laparoscopic hysterectomy for benign disease
  • Patient agrees to perform the 6-week follow-up assessment as per standard of care

排除标准

  • Any planned concomitant procedures (not including salpingectomy and/or oophorectomy)
  • Diagnosed malignant disease on reproductive organs
  • Uterus myomatous with fibroid > 10cm

结局指标

主要结局

Primary safety outcome

时间窗: up to 42 days after surgery

Occurrence of Clavien-Dindo grades III-V adverse events

Primary efficacy outcome

时间窗: Intraoperative

Successful completion of the DEXTER-assisted procedure, i.e. free of any conversion to an open or fully laparoscopic surgical approach

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验